March 17 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* WILL MOVE FORWARD WITH EUROPEAN REGULATORY AUTHORITY MEETINGS THIS YEAR TO DISCUSS RETT SYNDROME DEVELOPMENT PROGRAM
March 17 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* WILL MOVE FORWARD WITH EUROPEAN REGULATORY AUTHORITY MEETINGS THIS YEAR TO DISCUSS RETT SYNDROME DEVELOPMENT PROGRAM